| Cat.No. : |
CCL23-257H
Optional Service: Optional requirements on this protein
|
| Product Overview : |
Recombinant Human CCL23 (Accession # AAC63327) Met46-Asn137 was produced in E. coli-derived. |
| Source : |
E. coli |
| Species : |
Human |
| Predicted N Terminal : |
Met46 |
| Form : |
Lyophilized from a 0.2 µm filtered solution in Acetonitrile and TFA with BSA as a carrier protein. |
| Bio-activity : |
Measured by its ability to chemoattract THP-1 human acute monocytic leukemia cells.The ED50 for this effect is typically 0.01 - 0.04 µg/mL.Measured by its ability to chemoattract BaF3 mouse pro-B cells transfected with human CCR1.The ED50 for this effect is typically 0.002 - 0.01 µg/mL. |
| Molecular Mass : |
Recombinant Human CCL23 has a calculated MW of 10.5 kDa. |
| Purity : |
>97%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
| Storage : |
Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC). |
| Reconstitution : |
Reconstitute at 10 µg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin. |
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
